Viewing Study NCT05038332


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-01-02 @ 6:57 AM
Study NCT ID: NCT05038332
Status: RECRUITING
Last Update Posted: 2025-01-16
First Post: 2021-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: UMCC 2021.046
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators